Story perspectives
Health Canada OKs Moderna Ebola Trial; WHO Urges Phase III
8/11/2026
1 of 2
Canada Approves Ebola
- Health Canada approved Moderna's Phase I trial for Bundibugyo Ebola, enrolling 80 adults and pledging at least 500,000 doses for low- and middle-income countries if licensed.
- A WHO expert panel urged a Phase III trial of the Zaire Ebola vaccine Ervebo against Bundibugyo.
- WHO reported 3,748 cases, 1,657 deaths and 708 recoveries in the DRC as of 1 August.
- The outbreak spread to five provinces, prompting a 100-bed treatment centre in Bunia, Ituri province.
1 / 2
